Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cochlear ( (AU:COH) ) has shared an update.
Cochlear Limited has announced that its 2025 annual general meeting will be held as a hybrid event on October 23, 2025. The deadline for director nominations, excluding those recommended by the Board, is set for August 21, 2025. This announcement is significant for stakeholders as it outlines the timeline for governance activities and provides a framework for shareholder engagement.
The most recent analyst rating on (AU:COH) stock is a Buy with a A$311.00 price target. To see the full list of analyst forecasts on Cochlear stock, see the AU:COH Stock Forecast page.
More about Cochlear
Cochlear Limited operates in the medical device industry, specializing in implantable hearing solutions. The company focuses on developing and manufacturing cochlear implants and related products to improve hearing for individuals with severe to profound hearing loss.
YTD Price Performance: 7.55%
Average Trading Volume: 170,865
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$20.23B
See more insights into COH stock on TipRanks’ Stock Analysis page.